Stay updated on Tirzepatide in HFpEF & Obesity Clinical Trial

Sign up to get notified when there's something new on the Tirzepatide in HFpEF & Obesity Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tirzepatide in HFpEF & Obesity Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The SUMMIT trial record is displayed with details about tirzepatide for heart failure with preserved ejection fraction and obesity, including eligibility, treatment arms, outcome measures, locations, results-related publications, and data-sharing information.
    Difference
    100%
    Check dated 2026-11-08T23:23:49.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T23:30:56.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide NIH notice says that federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during a transition and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T22:48:51.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T23:08:16.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T23:13:41.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the detailed SUMMIT trial information with an access-restricted screen. This indicates a shift from content availability to an access issue, preventing users from viewing the study details.
    Difference
    19%
    Check dated 2026-09-20T22:30:07.000Z thumbnail image

Stay in the know with updates to Tirzepatide in HFpEF & Obesity Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tirzepatide in HFpEF & Obesity Clinical Trial page.